Abirateron Pharmascience 500 mg filmom obložene tablete
| Name | Abirateron Pharmascience 500 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-952941962 |
| Active Substance | abirateronacetat |
| Composition | svaka filmom obložena tableta sadrži 500 mg abirateronacetata |
| Pharmaceutical Form | Filmom obložena tableta |
| Packaging [MA Number for Packaging] | 56 tableta u blisteru, u kutiji [HR-H-952941962-01] 60 tableta u blisteru, u kutiji [HR-H-952941962-02] |
| Manufacturer | Bluepharma Industria Farmaceutica S.A., Coimbra, Portugal Bluepharma Industria Farmaceutica S.A., Coimbra, Portugal |
| Marketing Authorisation Holder | Pharmascience International Limited, Lampousas, 1, Nicosia, Cipar |
| Marketing Authorisation Date | 24.02.2022 |
| MA Period of Validity | 24.02.2027 |
| Classification Number | UP/I-530-09/21-01/19 |
| Registration Number | 381-12-01/70-22-04 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L02BX03 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
